Theratechnologies Inc T.TH

Cost effective trogarzo

[qwerty22]

https://www.rtihs.org/publications/cost-effectiveness-and-budget-impact-ibalizumab-uiyk-adults-multidrug-resistant-hiv-1

[palinc2000]

The author is in Health Economics ...I never heard of such profession....Did THTX pay for this report? This is a great argument to add to the equation

[scarlet1967]

https://stockhouse.com/companies/bullboard?symbol=t.th&postid=32607988

[scarlet1967]

Funding for this study was provided by Theratechnologies Inc. Authors maintained independent scientific control of the study design and analyses.

[qwerty22]

If you go back to my original link you can read the full paper. Their model assume a relatively slow uptake of Trogarzo "5% incremental uptake each year" Unfortunately my device won't allow copy and paste from that document, there's some interesting numbers spattered throughout the paper on the size of the market and uptake rates. I know this is a less important

[scarlet1967]

I didn't read the article but your calculations doesn't add up unless I am missing something so if the uptake is 5% of the total target market what that has to do with 20% growth YOY? The 5% uptake can result in 5% growth or 20% or 50% etc it depends on your base line numbers! For instance if they have 200 patients currently and their target  market is say 2000 a 5% uptake would